Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Packard BioScience

This article was originally published in The Gray Sheet

Executive Summary

Maker of instruments and related consumables for the life sciences research market, including drug discovery, genomics and biochip analysis, files for an initial public offering. Packard's primary products include microwell plate readers, imaging systems, automated liquid handling systems, laboratory robotics systems, bioanalytical spectrometers and biochemicals and related supplies. The IPO proceeds are tabbed for debt repayment, R&D and general corporate purposes. The Meriden, Connecticut firm recorded 1999 revenues of $264.9 mil., up 16.1%. A net loss of $198,000 compares to net income of $1.9 mil. in 1998. Underwriters include Merrill Lynch, Chase H&Q, and Robert Baird & Co

You may also be interested in...



Packard BioScience

Maker of instruments and related consumables for the life sciences research market, including drug discovery, genomics and biochip analysis, goes public April 20 via an initial offering of 12 mil. shares at $9 each and grosses $108 mil. The proceeds are tabbed for debt repayment, R&D, and general corporate purposes (1"The Gray Sheet" April 3, p. 22). Underwriters include Merrill Lynch, Chase H&Q, Robert Baird & Co., Banc of America Securities, and Thomas Weisel Partners

Civica Rx Gets $55m Investment

Civica Rx has won an investment of $55m through a deal with the Blue Cross Blue Shield Association of US health insurance firms to create a new subsidiary that will acquire and develop generic filings to be launched in the US from 2022.

UsernamePublicRestriction

Register

MT013201

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel